STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer.
Qureshy Z, Li H, Zeng Y, Rivera J, Cheng N, Peterson CN, Kim MO, Ryan WR, Ha PK, Bauman JE, Wang SJ, Long SR, Johnson DE, Grandis JR.
Qureshy Z, et al. Among authors: wang sj.
Clin Cancer Res. 2022 Nov 1;28(21):4737-4746. doi: 10.1158/1078-0432.CCR-22-0744.
Clin Cancer Res. 2022.
PMID: 35929989
Free PMC article.